Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma	High-risk Melanoma	Recruiting	Phase 3	2026-03-09		NCT06488482

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Falu Hospital	5
Gävle Hospital	6
Karlstad Central Hospital	4
Karolinska University Hospital	181
Norrlands University Hospital	8
Region Örebro County	65
Sahlgrenska University Hospital	158
Skane University Hospital	71
University Hospital, Linkoeping	50
Uppsala University	156
Västmanland County Council, Sweden	5

26 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Akershus University Hospital	Oslo	Norway	11
Eskilstuna Hospital	Eskilstuna	Sweden	4
Falu Hospital	Falun	Sweden	4
Gävle Hospital	Gävle	Sweden	12
Haukeland University Hospital	Bergen	Norway	52
Helsinki University Hospital	Helsinki	Finland	46
Kalmar Hospital	Kalmar	Sweden	6
Karlstad hospital	Karlstad	Sweden	4
Karolinska University Hospital	Stockholm	Sweden	87
Kuopio University Hospital	Kuopio	Finland	43
Linköping University Hospital	Linköping	Sweden	44
North Norway University Hospital	Tromsø	Norway	1
Oslo University Hospital	Oslo	Norway	111
Ryhov Hospital	Jönköping	Sweden	6
Sahlgrenska University Hospital	Gothenburg	Sweden	96
Skåne University Hospital	Lund	Sweden	39
Sorlandet hospital	Kristiansand	Norway	2
Stavanger University Hospital	Stavanger	Norway	36
Sundsvall Hospital	Sundsvall	Sweden	8
Tampere University Hospital	Tampere	Finland	61
Trondheim University Hospital	Trondheim	Norway	6
Turku University Hospital	Turku	Finland	61
Västmanland Hospital	Västerås	Sweden	2
Växjö Hospital	Vaxjo	Sweden	4
Ålesund Hospital	Ålesund	Norway	10

Clinical trials